NGF-ome: Its metabotrophic expression homage to Rita Levi-Montalcini

Biomedical Reviews

Volumn 21, Issue , 2010, Pages 25-29

  Chaldakov, George N ^a   Aloe, Luigi ^b   Hristova, Mariyana G ^a   Tonchev, Anton B ^a   Nikolova, Vesselka ^c   Panayotov, Plamen ^c   Ghenev, Peter I ^d  

^a MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

^b CNR   (Italy)

^c Clinic of Cardiovascular Surgery   (Bulgaria)

^d Department of General and Clinical Pathology ^*  (Bulgaria)

Author keywords

BDNF; Cardiometabolic diseases; Metabotrophins; NGF

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN; PROTEOME; TRANSCRIPTOME;

ARTICLE; CELL ACTIVITY; CELL SURVIVAL; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ENERGY BALANCE; GLUCOSE HOMEOSTASIS; HUMAN; METABOLIC SYNDROME X; NERVE GROWTH; OBESITY; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 84868705048     PISSN: 1310392X     EISSN: None     Source Type: Journal    
DOI: 10.14748/bmr.v21.44     Document Type: Article

References (51)

1. Sridhar GR, Thota H, Allam AR, Babu CS, Prasad AS, Divakar C. Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection? Lipids Health Dis 2006; 5: 28-31.
2. Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A, Sancarlo D, et al. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev 2010; 9: 399-417.
3. Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. J Alzheimer's Dis 2006; 9:13-33.
4. Manning S. Diabetes and dementia: a common link of coincidental coexistence. Biomed Rev 2007; 18: 59-64.
5. Milionis HJ, Florentin M, Giannopoulos S. Metabolic syndrome and Alzheimer's disease: A link to a vascular hypothesis? CNC Spectr 2008; 13: 606-613.
6. Molteni R, Barnard RJ, Ying Z, Roberts CK, Gómez-Pinilla F. A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience 2002; 112: 803-814.
7. de la Monte S, Wands JR. Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol 2008; 2: 1101-1113.
8. Chaldakov GN, Tonchev AB, Aloe L. NGF and BDNF: from nerves to adipose tissue, from neurokines to metabokines. Relevance to neuropsychiatric and cardiometabolic diseases. Riv Psichiatr 2009; 44: 79-87.
9. Chaldakov, G.N., Fiore, M., Ghenev, P.I., Stankulov, I.S., Aloe, L. Atherosclerotic lesions: possible interactive involvement of intima, adventition and associated adipose tissue. Int Med J 2000; 7: 43-49.
10. Chaldakov GN, Stankulov IS, Fiore M, Ghenev PI, Aloe L. Nerve growth factor levels and mast cell distribution in human coronary atherosclerosis. Atherosclerosis 2001; 159:57-66.
11. Trayhurn P, de Heredia FP, Wang B, de Oliveira C, González-Muniesa P, Wood, I.S. Cellular hypoxia: a key modulator of adipocyte function in obesity? Adipobiology 2009; 1: 19-26.
12. Chaldakov GN, Stankulov IS, Hristova M, Ghenev PI. Adipobiology of disease: adipokines and adipokine-targeted pharmacology. Curr Pharm Des 2003; 9: 1023-1031.
13. Catalán V, Rodríguez A, Becerril S, Sáinz N, Gómez-Ambrosi J, Frühbeck G. Adipopharmacology of inflammation and insulin resistance. Biomed Rev 2006; 17: 43-51
14. Després JP, Arsenault BJ, Côte M, Cartier A, Lemieux I. Abdominal obesity: the cholesterol of the 21st century? Can J Cardiol 2008; 24 (Suppl D): 7D-12D.
15. Palmieri L, Panico S, Vanuzzo D, Ferrario M, Pilotto L, Sega R, Cesana G, Giampaoli S; Gruppo di Ricerca del Progetto CUORE. Evaluation of the global cardiovascular absolute risk: the Progetto CUORE individual score. Ann Ist Super Sanita 2004; 40:393-399.
16. Shimabukuro M. Cardiac adiposity and global cardiometabolic risk: new concept and clinical implication. Circ J 2009; 73:27-34.
17. Duhne M, Myrian V, Larque C, Gutiérrez, Robles G, Hiriart M. Nerve growth factor, pancreatic beta cells, adipose tissue and diabetes mellitus. Adipobiology 2009; 1: 117A.
18. Chaldakov GN, Fiore M, Tonchev AB, Dimitrov D, Pancheva R, Rančič G, Aloe L. Homo obesus: a metabotrophin-deficient species. Pharmacology and nutrition insight. Curr Pharma Des 2007; 13, 2176-2179.
19. Chaldakov GN, Tonchev AB, Fiore F, Hristova MG, Pancheva R, Rancic G, Aloe L. Implications for the future of obesity management. In: Frühbeck G, editor. Peptides in Energy Balance and Obesity. CAB International. 2009, pp 370-389.
20. Aloe L, Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 1997; 133: 358-366.
21. Aloe L, Calzà L, editors. NGF and Related Molecules in Healthy and Disease (vol 146, Prog Brain Res). Elsevier, 2004.
22. Levi-Montalcini R. The nerve growth factors 35 years later. Science 1987; 237: 1154-1162.
23. Levi-Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A. Nerve growth factor: from neurotrophin to neurokine. Trend Neurosci 1996; 19: 514-520.
24. Levi-Montalcini R. The nerve growth factor and the neuroscience chess board. Arch Ital Biol 2003; 141: 85-88.
25. Aloe L, Tirassa P, Bracci-Laudiero L. Nerve growth factor in neurological and non-neurological diseases: basic findings and emerging pharmacological prospectives. Curr Pharm Des 2001; 7: 113-123.
26. Fiore M, Chaldakov GN, Aloe L. Nerve growth factor as a signaling molecule for nerve cells and also for the neuroendocrine-immune systems. Rev Neurosci 20:133-145, 2009.
27. Fainzilber M, Carter BD. From neurotrophins to immunotrophins. EMBO Reports 2002; 3: 1029-1034.
28. Lazarovici P, Marcinkiewicz C, Lelkes PI. Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr Pharm Des 2006; 12: 2609-2622.
29. Cabrera-Vásquez S, Navarro-Tableros V, Sánchez-Soto C, Gutiérrez-Ospina G, Hiriart M. Remodelling sympathetic innervation in rat pancreatic islets ontogeny. 2009; BMC Dev Biol 9: 34-44.
30. Rosenbaum T, Vidaltamayo R, Sánchez-Soto MC, Zentella A, Hiriart M. Pancreatic beta cells synthesize and secrete nerve growth factor. Proc Natl Acad Sci USA 95: 7784-7788, 1998.
31. Larrieta ME, Vital P, Mendoza-Rodriguez A, Cerbón M, Hiriart M. Nerve growth factor increases in pancreatic beta cells after streptozotocin-induced damage in rats. Exp Biol Med (Maywood) 2006; 231: 396-402.
32. Hiriart-Urdanivia M, Tableros VN, Velasco M, Larqué C, Cabrera-Vásquez S, Soto CS, et al. Insulin regulation in development and obesity. In: Hiriart-Urdanivia M, Mas-Oliva J, editors. Advances in obesity-diabetes research at UNAM (Universidad Nacional Autónoma de México). Manual Moderno, Mexico, Columbia. 2010; pp 69-79.
33. Abe T, Morgan DA, Gutterman DD. Protective role of nerve growth factor against postischemic dysfunction of sympathetic coronary innervation. Circulation 1997; 95: 213-220.
34. Hasan W, Jama A, Donohue T, Wernli G, Onyszchuk G, Al-Hafez B, Bilgen M, Smith PG. Sympathetic hyperinnervation and inflammatory cell NGF synthesis following myocardial infarction in rats. Brain Res 2006; 1124: 142-154.
35. Bulló M, Peeraully MR, Trayhurn P, Folch J, Salas-Salvadó J. Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women. Eur J Endocrinol 2007; 157: 303-310.
36. Cheng JT, Tong YC. Alterations of nerve-growth factor and p75(NTR) expressions in urinary bladder of fructose-fed obese rats. Neurosci Lett 2008; 441:25-28.
37. Kangavari S, Oh YS, Zhou S, Youn HJ, Lee MY, Jung WS, et al. Radiofrequency catheter ablation and nerve growth factor concentration in humans. Heart Rhythm 2006; 3: 1150-1155.
38. Sornelli F, Fiore M, Chaldakov GN, Aloe L. Adipose tissue-derived nerve growth factor and brain-derived neurotrophic factor: results from experimental stress and diabetes. Gen Physiol Biophys 2009; 28:179-83.
39. Sposato V, Manni L, Chaldakov GN, Aloe L. Streptozotocin-induced diabetes is associated with changes in NGF levels in pancreas and brain. Arch Ital Biol 2007; 145: 87-97.
40. Geroldi D, Minoretti P, Emanuele E. Brain-derived neurotrophic factor and the metabolic syndrome: More than just hypothesis. Med Hypotheses 2006; 67: 195-196.
41. Golden E, Emiliano A, Maudsley S, Windham BG, Carlson OD, Egan JM, et al. Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging. PLoS One. 2010;5: e10099.
42. Chaldakov GN, Fiore M, Tonchev AB, Aloe L. Neuroadipology: a novel component of neuroendocrinology. Cell Biol Int 2010; 34:1051-1053
43. Manni L, Nikolova V, Vyagova D, Chaldakov GN, Aloe L. Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. Int J Cardiol 2005; 102:169-171.
44. Wang C, Godar RJ, Billington CJ, Kotz CM. Chronic administration of brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus reverses obesity induced by high-fat diet. Am J Physiol Regul Integr Comp Physiol 2010; 298:R1320-1332.
45. Yamanaka M, Itakura Y, Ono-Kishino M, Tsuchida A, Nakagawa T, Taiji M. Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice. J Biosci Bioengen 2008; 105: 395-402.
46. Perry T, Lahiri DK, Chen D, Zhou J, Shaw KT, Egan JM, Greig NH. A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells. J Phramacol Exp Ther 2002; 300:958-966.
47. Clos J, Dicou E. Two peptides derived from the nerve growth factor precursor enhance cholinergic enzyme activities in vivo. Brain Res Dev Brain Res 1997; 99:267-270.
48. Dicou E. Multiple biological activities for two peptides derived from the nerve growth factor precursor. Biochem Biophys Res Commun 2006; 347: 833-837.
49. Dicou E. High levels of the proNGF peptides LIP1 and LIP2 in the serum and synovial fluid of rheumatoid arthritis patients: evidence for two new cytokines. J Neuroimmunol 2008; 194: 143-146.
50. Zhou S, Chen LS, Miyauchi Y, Miyauchi M, Kar S, Kangavari S, et al. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res 2004; 95: 76-83.
51. Ieda M, Fukuda K. Cardiac innervation and sudden cardiac death. Curr Cardiol Rev 2009; 5: 289-295.